These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19856722)

  • 1. Value of DNA-based assays for donor screening and regulatory issues.
    Strauss D; Reid ME
    Immunohematology; 2008; 24(4):175-9. PubMed ID: 19856722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion in the age of molecular diagnostics.
    Reid ME
    Hematology Am Soc Hematol Educ Program; 2009; ():171-7. PubMed ID: 20008196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular blood grouping of donors.
    St-Louis M
    Transfus Apher Sci; 2014 Apr; 50(2):175-82. PubMed ID: 24656492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood group genotyping: from patient to high-throughput donor screening.
    Veldhuisen B; van der Schoot CE; de Haas M
    Vox Sang; 2009 Oct; 97(3):198-206. PubMed ID: 19548962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications and Experience with PCR-Based Assays to Predict Blood Group Antigens.
    Reid ME
    Transfus Med Hemother; 2009 Jun; 36(3):168-178. PubMed ID: 20729996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular studies of DO alleles reveal that JO is more prevalent than HY in Brazil, whereas HY is more prevalent in New York.
    Castilho L; Baleotti W; Tossas E; Hue-Roye K; Ribeiro KR; Lomas-Francis C; Charles-Pierre D; Reid ME
    Immunohematology; 2008; 24(4):135-7. PubMed ID: 19856715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two robotic platforms to screen plateletpheresis donors for HLA antibodies as part of a transfusion-related acute lung injury mitigation strategy.
    Vassallo RR; Hsu S; Einarson M; Barone J; Brodsky J; Moroff G
    Transfusion; 2010 Aug; 50(8):1766-77. PubMed ID: 20345569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A flexible array format for large-scale, rapid blood group DNA typing.
    Hashmi G; Shariff T; Seul M; Vissavajjhala P; Hue-Roye K; Charles-Pierre D; Lomas-Francis C; Chaudhuri A; Reid ME
    Transfusion; 2005 May; 45(5):680-8. PubMed ID: 15847654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of blood group genotyping for transfusion medicine practice.
    Westhoff CM
    Immunohematology; 2008; 24(4):190-5. PubMed ID: 19856724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible automated platform for blood group genotyping on DNA microarrays.
    Paris S; Rigal D; Barlet V; Verdier M; Coudurier N; Bailly P; Brès JC
    J Mol Diagn; 2014 May; 16(3):335-42. PubMed ID: 24726279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine use of DNA testing for red cell antigens in blood centres.
    Jungbauer C
    Transfus Apher Sci; 2011 Aug; 45(1):61-8. PubMed ID: 21741314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors.
    Furuta RA; Ma G; Matsuoka M; Otani S; Matsukura H; Hirayama F
    Transfusion; 2015 Apr; 55(4):880-9. PubMed ID: 25363675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA analysis to find rare blood donors when antisera is not available.
    Reid ME
    Vox Sang; 2002 Aug; 83 Suppl 1():91-3. PubMed ID: 12617111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass-scale red cell genotyping of blood donors: from data visualization to historical antigen labeling and donor recruitment.
    Denomme GA; Anani WQ
    Transfusion; 2019 Sep; 59(9):2768-2770. PubMed ID: 31246285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass-scale high-throughput multiplex polymerase chain reaction for human platelet antigen single-nucleotide polymorphisms screening of apheresis platelet donors.
    Shehata N; Denomme GA; Hannach B; Banning N; Freedman J
    Transfusion; 2011 Sep; 51(9):2028-33. PubMed ID: 21392014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-Mur screening and Mur antigen genotyping of voluntary blood donors in Guangzhou].
    Wei L; Ji Y; Mo C; Zhang R; Zhao Y; Luo H; Wang Z; Luo G
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1833-5. PubMed ID: 23268422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified expression of the KEL2 (k) blood group antigen attributed to p.Leu196Val amino acid change three residues from the K/k antigen polymorphism site: implications for donor screening.
    Millard GM; Lopez GH; Turner EM; Lizarazu ME; Roots NM; Liew YW; Flower RL; Hyland CA
    Transfusion; 2019 Mar; 59(3):1156-1158. PubMed ID: 30586164
    [No Abstract]   [Full Text] [Related]  

  • 18. Principles of PCR-based assays.
    Hue-Roye K; Vege S
    Immunohematology; 2008; 24(4):170-5. PubMed ID: 19856721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing a reentry procedure for human immunodeficiency virus screening-reactive donors in China.
    Li L; Xu T; Yang T; Zang L; Cheng W; Lin H; Zhu S; Zhao B; Duan R; Li C; Huang M; Liu Y; Ming C; Xu S; Wang C; Wu Y; Liu Z
    Transfusion; 2016 Jan; 56(1):195-202. PubMed ID: 26360920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood group genotyping by high-throughput DNA analysis applied to 356 reagent red blood cell samples.
    Kappler-Gratias S; Peyrard T; Beolet M; Amiranoff D; Menanteau C; Dubeaux I; Rouger P; Cartron JP; Le Pennec PY; Pham BN
    Transfusion; 2011 Jan; 51(1):36-42. PubMed ID: 20707859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.